The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cosman, Felicia
  • Crittenden, Daria B
  • Ferrari, Serge
  • Khan, Aliya
  • Lane, Nancy E
  • Lippuner, Kurt
  • Matsumoto, Toshio
  • Milmont, Cassandra E
  • Libanati, Cesar
  • Grauer, Andreas

publication date

  • October 2017